Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.
Most Streptococcus pneumoniae strains are killed by very low concentrations of penicillin and other beta-lactam antibiotics, yet middle ear inflammation and effusion persist for days to weeks after treatment in most cases of pneumococcal otitis media. To study the effect of beta-lactam antibiotic treatment on pneumococci and the middle ear inflammatory response during pneumococcal otitis media, we measured concentrations of pneumococci, inflammatory cells, and lysozyme in middle ear fluid (MEF) by using the chinchilla model. Procaine penicillin G given intramuscularly 12 and 36 h after inoculation of pneumococci into the middle ear caused a significant acceleration in the MEF inflammatory cell concentration compared with that in untreated controls, with a significant peak in the inflammatory cell concentration 24 h after pneumococcal inoculation. The lysozyme concentration in MEF also increased more rapidly in treated than in control animals. Viable pneumococci were not detected in MEF after the second dose of penicillin, but the total pneumococcal cell concentration remained unchanged for at least 45 days. Therefore, penicillin treatment accelerated middle ear inflammation while killing pneumococci, but treatment did not accelerate clearance of the nonviable pneumococcal cells from MEF. Further studies will need to define the contribution of these responses to acute and chronic tissue injury.
Kawana
M
M
Otitis Media Research Center, University of Minnesota School of Medicine, Minneapolis 55455.
Kawana
C
C
Giebink
G S
GS
D000818:Animals; D002682:Chinchilla; D009113:Muramidase / Q000032:analysis; D010033:Otitis Media / Q000473:pathology*; D010406:Penicillins / Q000633:toxicity*; D011008:Pneumococcal Infections / Q000473:pathology*
D010406:Penicillins; D009113:Muramidase